• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy of Bimekizumab in the Management of Refractory Erythrodermic Pityriasis Rubra Pilaris: Clinical Insights.

作者信息

Theotokoglou Sofia, Sgouros Dimitrios, Theodoropoulos Konstantinos, Syrmali Anna, Pappa Georgia, Katoulis Alexandros

机构信息

2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, "Attikon" General University Hospital, Athens, Greece.

出版信息

Dermatol Pract Concept. 2025 Jul 31;15(3):5316. doi: 10.5826/dpc.1503a5316.

DOI:10.5826/dpc.1503a5316
PMID:40790415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12339111/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bdb/12339111/192caa7d5116/dp1503a5316g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bdb/12339111/15b9c1db4bb9/dp1503a5316g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bdb/12339111/192caa7d5116/dp1503a5316g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bdb/12339111/15b9c1db4bb9/dp1503a5316g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bdb/12339111/192caa7d5116/dp1503a5316g002.jpg

相似文献

1
Efficacy of Bimekizumab in the Management of Refractory Erythrodermic Pityriasis Rubra Pilaris: Clinical Insights.比美吉珠单抗治疗难治性红皮病型毛发红糠疹的疗效：临床见解
Dermatol Pract Concept. 2025 Jul 31;15(3):5316. doi: 10.5826/dpc.1503a5316.
2
Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab.用比美吉珠单抗治疗的新型冠状病毒2型疫苗接种后发生的红皮病型毛发红糠疹
JAAD Case Rep. 2023 Oct 4;42:7-11. doi: 10.1016/j.jdcr.2023.09.024. eCollection 2023 Dec.
3
Bimekizumab in refractory pityriasis rubra pilaris.比美吉珠单抗治疗难治性毛发红糠疹
J Dtsch Dermatol Ges. 2024 Jan;22(1):102-104. doi: 10.1111/ddg.15252. Epub 2023 Dec 8.
4
Efficacy and safety of small molecule drugs in the treatment of pityriasis rubra pilaris-A systematic review.小分子药物治疗毛发红糠疹的疗效与安全性——一项系统评价
Front Med (Lausanne). 2025 Feb 25;12:1544197. doi: 10.3389/fmed.2025.1544197. eCollection 2025.
5
Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.司库奇尤单抗治疗成人发病性毛发红糠疹：一项带有转录组分析的单臂临床试验。
Br J Dermatol. 2022 Nov;187(5):650-658. doi: 10.1111/bjd.21708. Epub 2022 Jul 15.
6
Tofacitinib for Pityriasis Rubra Pilaris: A Case Report.托法替布治疗毛发红糠疹：一例报告
Clin Cosmet Investig Dermatol. 2024 Aug 26;17:1917-1920. doi: 10.2147/CCID.S470170. eCollection 2024.
7
Rapid improvement of severe pityriasis rubra pilaris upon treatment with bimekizumab.使用比美吉珠单抗治疗后严重毛发红糠疹迅速改善。
Int J Dermatol. 2024 Oct;63(10):1454-1455. doi: 10.1111/ijd.17207. Epub 2024 May 8.
8
A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists.一项关于 TNF 拮抗剂治疗 1 型毛发红糠疹的文献系统回顾。
J Eur Acad Dermatol Venereol. 2013 Jan;27(1):e131-5. doi: 10.1111/j.1468-3083.2012.04456.x. Epub 2012 Feb 10.
9
Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review.红皮病型毛发红糠疹的治疗：两例病例报告及文献综述
Dermatol Ther. 2020 Nov;33(6):e14223. doi: 10.1111/dth.14223. Epub 2020 Sep 9.
10
[Acute pityriasis rubra pilaris in the child. Apropos of 4 cases].[儿童急性毛发红糠疹。附4例报告]
Ann Dermatol Venereol. 1983;110(3):221-8.

本文引用的文献

1
Bimekizumab in refractory pityriasis rubra pilaris.比美吉珠单抗治疗难治性毛发红糠疹
J Dtsch Dermatol Ges. 2024 Jan;22(1):102-104. doi: 10.1111/ddg.15252. Epub 2023 Dec 8.
2
Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab.用比美吉珠单抗治疗的新型冠状病毒2型疫苗接种后发生的红皮病型毛发红糠疹
JAAD Case Rep. 2023 Oct 4;42:7-11. doi: 10.1016/j.jdcr.2023.09.024. eCollection 2023 Dec.
3
Treatment of pityriasis rubra pilaris with risankizumab in two cases.两例用司库奇尤单抗治疗红皮病型毛发红糠疹的病例
J Dtsch Dermatol Ges. 2021 Aug;19(8):1207-1209. doi: 10.1111/ddg.14504. Epub 2021 May 10.
4
Systemic therapies of pityriasis rubra pilaris: a systematic review.系统性治疗毛发红糠疹：系统评价。
J Dtsch Dermatol Ges. 2019 Mar;17(3):243-259. doi: 10.1111/ddg.13718. Epub 2018 Dec 6.
5
Biologics for pityriasis rubra pilaris treatment: A review of the literature.生物制剂治疗毛发红糠疹：文献综述。
J Am Acad Dermatol. 2018 Aug;79(2):353-359.e11. doi: 10.1016/j.jaad.2018.03.036. Epub 2018 Mar 30.
6
Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris.白细胞介素 23-辅助性 T 细胞 17 轴作为治疗毛发红糠疹的靶点。
JAMA Dermatol. 2017 Apr 1;153(4):304-308. doi: 10.1001/jamadermatol.2016.5384.